Position in RGNX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$200,282
+$103,396 QoQ
Shares Held
23,900
+138.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. RGNX ranks #98 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.DE
|
563,999 | $11,031,820 |
All Filings in RGNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200,282 | 23,900 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $96,886 | 10,040 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $166,236 | 20,248 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $354,482 | 49,578 | Shares | Sole | 2025-05-13 | |
| 2023-12-31 | $322,920 | 17,990 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $367,512 | 11,073 | Shares | Sole | 2022-05-16 | |
| 2020-12-31 | $1,366,424 | 30,124 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $516,853 | 18,781 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||